Absci Corp. (ABSI)

6.60 +0.05 (+0.76%) USD  |  NASDAQ  |  Jun 09, 11:16
More

Absci SG&A Expense (Quarterly) : 9.058M for March 31, 2026

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for ABSI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. 5.034M
Exicure, Inc. 1.291M
Century Therapeutics, Inc. 6.579M
Celularity, Inc. 15.06M
Cardio Diagnostics Holdings, Inc. 1.652M